Related Experiment Video
Updated: May 25, 2026
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Structural neuroimaging in aging and Alzheimer's disease
Meike W Vernooij1, Marion Smits
1Department of Radiology, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. m.vernooij@erasmusmc.nl
Neuroimaging Clinics of North America
|January 31, 2012
Summary
Understanding normal brain aging through magnetic resonance (MR) imaging is crucial for diagnosing Alzheimer's disease (AD). This review covers MR imaging markers for normal aging and their role in AD diagnosis.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Structural neuroimaging plays a vital role in diagnosing Alzheimer's disease (AD).
- Distinguishing normal aging brain changes from pathological changes is essential for accurate diagnosis.
- Magnetic resonance (MR) imaging provides key markers for assessing brain aging.
Purpose of the Study:
- To review normal brain aging processes using qualitative and quantitative MR imaging markers.
- To examine the application of MR imaging in the diagnosis and differential diagnosis of AD.
Main Methods:
- Discussion of qualitative MR imaging findings in normal aging.
- Analysis of quantitative MR imaging metrics associated with brain aging.
- Review of MR imaging's utility in identifying AD-related brain changes.
Main Results:
- Normal aging is characterized by specific patterns of brain volume changes and tissue alterations detectable by MR imaging.
- Pathological aging, as seen in AD, exhibits distinct MR imaging features that differentiate it from normal aging.
- MR imaging aids in the differential diagnosis of AD by highlighting characteristic neuroanatomical changes.
Conclusions:
- A thorough understanding of normal aging via MR imaging is fundamental for detecting pathological changes indicative of AD.
- MR imaging is a valuable tool for both diagnosing AD and differentiating it from other neurodegenerative conditions.
- The application of structural neuroimaging, particularly MR imaging, is increasingly critical in the clinical management of Alzheimer's disease.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...